Skip to main content

Table 4 Classification of Economic Impact and Quantifying of Cost Saving

From: Clinical, economic and organizational impact of pharmacist interventions on injectable antineoplastic prescriptions: a prospective observational study

Economic impact

Number of interventions (%)

Costs

−1: Negative

38 (16.0)

11, 878 €

0: Null

94 (39.7)

0 €

+ 1: Positive

105 (44.3)

15,096 €

Total benefit

 

3218 €

Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us